Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

2.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

3.

Clinical trial is testing whether heavy lifting could combat cancer side effects

4.

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

5.

Dual-action mRNA vaccine takes aim at aggressive skin cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot